Rigel insider disposes 877 shares for taxes

Rigel Pharmaceuticals’ EVP and general counsel reported 877 shares withheld to cover option exercise price or taxes, leaving 50,559 shares held directly.

Rhea-AI Filing Summary

RIGEL PHARMACEUTICALS INC (RIGL) reported that executive vice president, general counsel, chief compliance officer and corporate secretary Raymond J. Furey had 877 shares of common stock disposed of on September 1, 2026 as a payment of exercise price or tax liability by delivering or withholding securities at $47.50 per share. After this transaction, he directly holds 50,559 shares of common stock, which includes 500 shares acquired under the issuer's stock purchase plan.

Insider Trade Summary

Exercise Price or Tax Liability: 877 shares

Exercise Price or Tax Liability 1 txn

Insider Furey Raymond J.

Role EVP, GC, CCO & Corp Sec

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock F1	877	$47.50	$42K

Holdings After Transaction: Common Stock — 50,559 shares (Direct)

Footnotes (1)

1. F1. Includes 500 shares acquired under the Issuer's stock purchase plan.

Key Figures

Shares disposed for exercise price or tax liability: 877 shares Transaction price per share: $47.50 per share Shares held after transaction: 50,559 shares +1 more

4 metrics

Shares disposed for exercise price or tax liability 877 shares Common stock delivered or withheld on September 1, 2026

Transaction price per share $47.50 per share Used to value the 877-share disposition on September 1, 2026

Shares held after transaction 50,559 shares Direct common stock holdings of Raymond J. Furey after the Form 4 transaction

Shares from stock purchase plan 500 shares Included within post-transaction holdings of 50,559 shares

Key Terms

Payment of exercise price or tax liability by delivering or withholding securities, stock purchase plan, directly holds

3 terms

Payment of exercise price or tax liability by delivering or withholding securities financial

"The transaction was a payment of exercise price or tax liability"

stock purchase plan financial

"Includes 500 shares acquired under the Issuer's stock purchase plan"

A stock purchase plan is a company-run program that lets employees or qualifying investors buy the company’s shares regularly, often through paycheck deductions and sometimes at a discounted price or with matching contributions. It matters because it encourages ownership—like a workplace discount for buying company products—aligning interests between holders and managers, while affecting share supply and potential value for outside investors.

directly holds financial

"After this transaction, he directly holds 50,559 shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did RIGL report for Raymond J. Furey on September 1, 2026?

RIGEL PHARMACEUTICALS INC reported that Raymond J. Furey had 877 common shares disposed of on September 1, 2026 as a payment of exercise price or tax liability by delivering or withholding securities at $47.50 per share.

How many RIGL shares does Raymond J. Furey hold after this Form 4 transaction?

After the reported transaction, Raymond J. Furey directly holds 50,559 shares of RIGEL PHARMACEUTICALS INC common stock, according to the filing.

Was the RIGL insider transaction a market sale or a tax/exercise-related disposition?

The Form 4 states the transaction was a payment of exercise price or tax liability by delivering or withholding securities, not a regular open-market sale, involving 877 shares at $47.50 per share.

Does the RIGL Form 4 indicate use of a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the 877-share transaction on September 1, 2026 was made under a Rule 10b5-1 trading plan.

What portion of Raymond J. Furey’s RIGL holdings comes from the stock purchase plan?

A footnote explains that Raymond J. Furey’s reported holdings include 500 shares that were acquired under the issuer's stock purchase plan, within his total of 50,559 shares held after the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 07:00 PM Accepted by SEC EDGAR 09/03/2026 - 06:59 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Furey Raymond J.

(Last) (First) (Middle)

RIGEL PHARMACEUTICALS, INC.

611 GATEWAY BLVD, SUITE 900

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RIGEL PHARMACEUTICALS INC [ RIGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, GC, CCO & Corp Sec

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		F		877	D	$47.5	50,559(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 500 shares acquired under the Issuer's stock purchase plan.

	/s/ Raymond Furey	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)